Clicky

Regeneron Pharmaceuticals Inc(RGO) News

Date Title
Feb 26 Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
Feb 25 Regeneron Pharmaceuticals, Inc. (REGN): Among the Stocks That Will Go to The Moon According to Analysts
Feb 24 Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial
Feb 24 Regeneron Pharmaceuticals (REGN): Among the Best Growth Stocks to Invest In According to Analysts
Feb 24 The Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis
Feb 21 2 Healthcare Stocks with Big Upside and 1 to Skip
Jan 28 Earnings Preview: Regeneron (REGN) Q4 Earnings Expected to Decline
Jan 28 Implied Volatility Surging for Regeneron Pharmaceuticals (REGN) Stock Options
Jan 28 Is Regeneron Pharmaceuticals (REGN) Among the Best Depressed Stocks to Invest in Now?
Jan 28 Drugmakers Show Restraint on Price Increases in New Trump Era
Jan 27 Is Regeneron Pharmaceuticals (REGN) the Best Stock to Buy and Hold for 2025?
Jan 24 Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Falling Stock to Invest in Right Now?
Jan 23 America's Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
Jan 21 REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES